307 related articles for article (PubMed ID: 20415504)
1. Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.
Navath RS; Menjoge AR; Wang B; Romero R; Kannan S; Kannan RM
Biomacromolecules; 2010 Jun; 11(6):1544-63. PubMed ID: 20415504
[TBL] [Abstract][Full Text] [Related]
2. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
3. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
5. Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.
Kim Y; Klutz AM; Jacobson KA
Bioconjug Chem; 2008 Aug; 19(8):1660-72. PubMed ID: 18610944
[TBL] [Abstract][Full Text] [Related]
6. Ultrafast in situ forming poly(ethylene glycol)-poly(amido amine) hydrogels with tunable drug release properties via controllable degradation rates.
Buwalda SJ; Bethry A; Hunger S; Kandoussi S; Coudane J; Nottelet B
Eur J Pharm Biopharm; 2019 Jun; 139():232-239. PubMed ID: 30954658
[TBL] [Abstract][Full Text] [Related]
7. Modified Carboxyl-Terminated PAMAM Dendrimers as Great Cytocompatible Nano-Based Drug Delivery System.
Vu MT; Bach LG; Nguyen DC; Ho MN; Nguyen NH; Tran NQ; Nguyen DH; Nguyen CK; Hoang Thi TT
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022905
[TBL] [Abstract][Full Text] [Related]
8. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of efficient gene delivery systems by grafting pegylated alkylcarboxylate chains to PAMAM dendrimers: Evaluation of transfection efficiency and cytotoxicity in cancerous and mesenchymal stem cells.
Ayatollahi S; Hashemi M; Oskuee RK; Salmasi Z; Mokhtarzadeh A; Alibolandi M; Abnous K; Ramezani M
J Biomater Appl; 2015 Nov; 30(5):632-48. PubMed ID: 26265706
[TBL] [Abstract][Full Text] [Related]
10. Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
Parsian M; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
Int J Pharm; 2016 Dec; 515(1-2):104-113. PubMed ID: 27725272
[TBL] [Abstract][Full Text] [Related]
11. A novel dendrimer based on poly (L-glutamic acid) derivatives as an efficient and biocompatible gene delivery vector.
Zeng X; Pan S; Li J; Wang C; Wen Y; Wu H; Wang C; Wu C; Feng M
Nanotechnology; 2011 Sep; 22(37):375102. PubMed ID: 21852739
[TBL] [Abstract][Full Text] [Related]
12. Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.
Leng ZH; Zhuang QF; Li YC; He Z; Chen Z; Huang SP; Jia HY; Zhou JW; Liu Y; Du LB
Carbohydr Polym; 2013 Oct; 98(1):1173-8. PubMed ID: 23987460
[TBL] [Abstract][Full Text] [Related]
13. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
14. Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy.
Palmerston Mendes L; Pan J; Torchilin VP
Molecules; 2017 Aug; 22(9):. PubMed ID: 28832535
[TBL] [Abstract][Full Text] [Related]
15. PAMAM dendrimers with an oxyethylene unit-enriched surface as biocompatible temperature-sensitive dendrimers.
Li X; Haba Y; Ochi K; Yuba E; Harada A; Kono K
Bioconjug Chem; 2013 Feb; 24(2):282-90. PubMed ID: 23297782
[TBL] [Abstract][Full Text] [Related]
16. Effects of PAMAM dendrimers with various surface functional groups and multiple generations on cytotoxicity and neuronal differentiation using human neural progenitor cells.
Zeng Y; Kurokawa Y; Win-Shwe TT; Zeng Q; Hirano S; Zhang Z; Sone H
J Toxicol Sci; 2016; 41(3):351-70. PubMed ID: 27193728
[TBL] [Abstract][Full Text] [Related]
17. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
Malik N; Wiwattanapatapee R; Klopsch R; Lorenz K; Frey H; Weener JW; Meijer EW; Paulus W; Duncan R
J Control Release; 2000 Mar; 65(1-2):133-48. PubMed ID: 10699277
[TBL] [Abstract][Full Text] [Related]
18. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.
Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J
J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825
[TBL] [Abstract][Full Text] [Related]
19. In vitro mammalian cytotoxicological study of PAMAM dendrimers - towards quantitative structure activity relationships.
Mukherjee SP; Davoren M; Byrne HJ
Toxicol In Vitro; 2010 Feb; 24(1):169-77. PubMed ID: 19778601
[TBL] [Abstract][Full Text] [Related]
20. gamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devices.
Uehara T; Ishii D; Uemura T; Suzuki H; Kanei T; Takagi K; Takama M; Murakami M; Akizawa H; Arano Y
Bioconjug Chem; 2010 Jan; 21(1):175-81. PubMed ID: 20000792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
